Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 16;15(18):5927-5941.
doi: 10.7150/jca.93930. eCollection 2024.

Exploration of the carcinogenetic and immune role of CHK1 in human cancer

Jian Zhou  1 , Ziyi Wu  1 , Dilihumaer Aili  2 , Lu Wang  1 , Tang Liu  1
Affiliations

Exploration of the carcinogenetic and immune role of CHK1 in human cancer

Jian Zhou et al. J Cancer. .

Abstract

Background: Previous study indicated that CHK1 was important for repairing DNA damage and cell cycle regulation. Aims: To investigate the association of Checkpoint kinase 1 (CHK1) expression with clinicopathological features, prognosis, and immune infiltration in cancer. Methods: Several databases were searched for relevant publications to conduct a meta-analysis to reveal the association between CHK1 and clinicopathological features of cancer. TIMER and GEPIA datasets were utilized to explore the differential expression of CHK1 of tumors. GEPIA and Kaplan-Meier Plotter databases were adopted to detect the prognostic significance of CHK1 in tumor. TIMER and cBioPortal databases were used for the analysis regarding immune infiltration and mutation respectively. Results: We found that CHK1 expression was significantly associated with low differentiation (OR=3.94, 95% CI: 2.73-5.67, P<0.05), advanced stage (OR=3.20, 95% CI: 2.30-4.44, P<0.05), vascular infiltration (OR=3.24, 95% CI: 2.18-4.82, P<0.05) and lymph node metastasis (OR=3.55, 95% CI: 2.62-4.82, P<0.05) of various cancers. CHK1 was highly expressed in multiple cancers and was related to clinical stage, survival, immune infiltration in pan-cancers. Conclusions: Our study found that CHK1 was significantly related to prognosis and immunological status in various cancers, suggesting that CHK1 may serve as a useful biomarker for prognosis and immune infiltration in cancer.

Keywords: CHK1; Clinicopathological features; Immune infiltration.; Pan-cancer; Prognosis.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
The flow chart of article selection.
Figure 2
Figure 2
Association between CHK1 and clinicopathological feature in various cancers. (A-C) Forest plot, sensitivity analysis and funnel plot for association between CHK1 and cancer differentiation. (D-F) Forest plot, sensitivity analysis and funnel plot for association between CHK1 and cancer clinical stage. (G-I) Forest plot, sensitivity analysis and funnel plot for association between CHK1 and cancer vascular infiltration. (J-L) Forest plot, sensitivity analysis and funnel plot for association between CHK1 and cancer lymph node metastasis.
Figure 3
Figure 3
The expression of CHK1 in human cancers and clinicopathological stages. (A) Data from ONCOMINE database. Red cells: gene overexpression. Blue cells: decreased gene expression. Numbers: evidential frequencies. (B) CHK1 expression status in multiple tumors detect using TIMER dataset. **P < 0.01; ***P <0.001. (C) Differential expression of CHK1 in TCGA project. *P <0.05. (D) Differential expression of CHK1 protein in CPTAC dataset. *** P < 0.001. (E) Correlation between CHK1 and clinical stages.
Figure 4
Figure 4
Association between CHK1 and clinical outcome of cancers in TCGA. (A) Overall survival, (B) Disease-free survival.
Figure 5
Figure 5
The prognostic significance of CHK1 in cancer patients. (A) Overall survival, (B) Relapse-free survival.
Figure 6
Figure 6
Mutation patterns of CHK1 in different cancer of TCGA. (A) Mutation type, (B) Mutation site, (C) The 3D structure of mutation site with the highest alteration frequency, (D) Association between mutation status and overall survival, disease-specific survival, disease-free survival, and progression-free survival in UCEC.
Figure 7
Figure 7
Enrichment analysis of CHK1 interacted or associated genes. (A) Experimentally determined interacted genes of CHK1. (B) Top 5 CHK1 associated genes in TCGA projects. (C) The corresponding heatmap map for correlation between CHK1 and top 5 related genes in various cancers. (D) An intersection analysis of CHK1 interacted and associated genes. (E) KEGG pathway analysis of CHK1 interacted or associated genes. (F) GO analysis of CHK1 interacted or associated genes.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
    1. Zhou J, Liu T, Wang W. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies. Medicine. (Baltimore) 2018;97:e13051. - PMC - PubMed
    1. Nedelcu T, Kubista B, Koller A, Sulzbacher I, Mosberger I, Arrich F. et al. Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res Clin Oncol. 2008;134:237–244. - PubMed
    1. Onishi M, Fujita Y, Yoshikawa H, Yamashita T. Inhibition of Rac1 promotes BMP-2-induced osteoblastic differentiation. Cell Death Dis. 2013;4:e698. - PMC - PubMed
    1. Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A. et al. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32:3307–3329. - PMC - PubMed

LinkOut - more resources